The Russian cancer vaccine is ready for use, Izvestia reported, citing Veronika Skvortsova, head of the Federal Medical-Biological Agency.
Preclinical studies have confirmed the safety and efficacy of the drug. At the end of the summer, the FMBA sent documents to the Ministry of Health to obtain permission for clinical use.
As previously reported, from September 2025, the vaccine will be used to treat patients with primary melanoma, as well as those who have undergone certain stages of therapy. The drug was developed by the Gamaleya Research Center for Epidemiology and Microbiology.
Read materials on the topic:
Russian cancer vaccine has successfully passed preclinical trials
Now on home
Start of deliveries scheduled for 2027
Over 51,000 new motorcycles were sold in Russia in 2025
The car will take at least a year to assemble
The application's audience has reached 20 million users
The model will be included in the list of cars for taxis, price - from 2.25 million rubles
All parking lots of the "Administrator of the Moscow Parking Space" are connected to the service
The cars will be supplied to the Moscow Transport Service Directorate
Deliveries to India may begin in 2028
The technology provides automated search for all types of defects in power units
The plane flew 500 km, accelerating to 425 km/h
The plant stated that the information about the termination of purchases for models 6 and 8 is not true
Scientists are using the "Ekran-M" installation